Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Long-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Croatia Czechia France Germany Greece +2
  • Study of atrasentan in children aged 2 to <18 years with primary IgA nephropathy to evaluate proteinuria reduction, safety and tolerability

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Spain
  • Study on Corticosteroids, Dapagliflozin, and Drug Combination for Proteinuria in IgA Nephropathy Patients with Active or Chronic Kidney Lesions

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Italy
  • Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark France Germany Hungary +6
  • Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Croatia Czechia Estonia France Germany +5
  • Study of Ravulizumab for Adults with Lupus Nephritis or IgA Nephropathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Poland Spain +1
  • Study on Vemircopan for Adults with Lupus Nephritis or IgA Nephropathy

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy Spain
  • Study on the Effectiveness and Safety of Ravulizumab for Adults with Corticosteroid-Resistant IgA Nephropathy Flares

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +6
  • Study on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression

    Not recruiting

    3 1 1
    Investigated Drugs:
    Czechia France Germany Greece Italy Poland +1